Print this page    •   Back to Web version of article

Chronic Pain: Hope Through Research
A New Look at Pain Treatments

National Institute of Neurological Disorders and Stroke

September, 1997

Further evidence that endorphins figure importantly in pain control comes from a new look at some of the oldest and newest pain treatments. The new look frequently involves the use of a drug that prevents endorphins and morphine from working. Injections of this drug, naloxone, can result in a return of pain which had been relieved by morphine and certain other treatments. But, interestingly, some pain treatments are not affected by naloxone: Their success in controlling pain apparently does not depend on endorphins. Thus nature has provided us with more than one means of achieving pain relief.

As research continues to reveal the role of endorphins in the brain, neuroscientists have been able to draw more detailed brain maps of the areas and pathways important in pain perception and control. They have even found new members of the endorphin family: Dynorphin, the newest endorphin, is reported to be 10 times more potent a painkiller than morphine.

At the same time, clinical investigators have tested chronic pain patients and found that they often have lower-than-normal levels of endorphins in their spinal fluid. If you could just boost their stores with man-made endorphins, perhaps the problems of chronic pain patients could be solved.

Not so easy. Some endorphins are quickly broken down after release from nerve cells. Other endorphins are longer lasting, but there are problems in manufacturing the compounds in quantity and getting them into the right places in the brain or spinal cord. In a few promising studies, clinical investigators have injected an endorphin called beta-endorphin under the membranes surrounding the spinal cord. Patients reported excellent pain relief lasting for many hours. Morphine compounds injected in the same area are similarly effective in producing long-lasting pain relief.

But spinal cord injections or other techniques designed to raise the level of endorphins circulating in the brain require surgery and hospitalization. And even if less,drastic means of getting endorphins into the nervous system could be found, they are probably not the ideal answer to chronic pain. Endorphins are also involved in other nervous system activities such as controlling blood flow. Increasing the amount of endorphins might have undesirable effects on these other body activities. Endorphins also appear to share with morphine a potential for addiction or tolerance.

Meanwhile, chemists are synthesizing new analgesics and discovering painkilling virtues in drugs not normally prescribed for pain. Much of the drug research is aimed at developing nonnarcotic painkillers. The motivation for the research is not only to avoid introducing potentially addictive drugs on the market, but is based on the observation that narcotic drugs are simply not effective in treating a variety of chronic pain conditions. Developments in nondrug treatments are also progressing, ranging from new surgical techniques to physical and psychological therapies like exercise, hypnosis, and biofeedback.

Back | Next
Table of Contents




This article was provided by U.S. National Institutes of Health. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art6345.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.